Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dickson

Showing results (371-380 of 520) with videos related to

Pageof 52
Sort By:
The Lancet Regional Health. Western Pacific|September 16, 2024
Antimicrobial susceptibility profiles of invasive bacterial infections among children from low- and middle-income countries in the Western Pacific Region (WPRO) - a systematic review and meta-analysisNerida Moore, Elizabeth A Ashley, Benjamin F R Dickson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancerT Brown, A Boland, A Bagust, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2013
Assessing variation in the costs of care among patients awaiting liver transplantationD A Axelrod, N Dzebisashvili, K Lentine, et al.
Hepatology (Baltimore, Md.)|December 24, 1998
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosisT Pasha, J Heathcote, S Gabriel, et al.
Transplantation Proceedings|February 1, 1987
Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patientsJ D Perkins, S Sterioff, R H Wiesner, et al.
Journal of Patient-Reported Outcomes|February 28, 2024
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapyNatalie R Dickson, Karen D Beauchamp, Toni S Perry, et al.
The New England Journal of Medicine|April 18, 1985
Trial of penicillamine in advanced primary biliary cirrhosisE R Dickson, T R Fleming, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|May 1, 1992
Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?J S Crippin, K D Lindor, R Jorgensen, et al.
Hepatology (Baltimore, Md.)|January 1, 1989
Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain alpha-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigenC D Surh, D J Danner, A Ahmed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complexD R Fregeau, P A Davis, D J Danner, et al.
Pageof 52

Showing results (371-380 of 520) with videos related to

Sort By:
Pageof 52
The Lancet Regional Health. Western Pacific|September 16, 2024
Antimicrobial susceptibility profiles of invasive bacterial infections among children from low- and middle-income countries in the Western Pacific Region (WPRO) - a systematic review and meta-analysisNerida Moore, Elizabeth A Ashley, Benjamin F R Dickson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancerT Brown, A Boland, A Bagust, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2013
Assessing variation in the costs of care among patients awaiting liver transplantationD A Axelrod, N Dzebisashvili, K Lentine, et al.
Hepatology (Baltimore, Md.)|December 24, 1998
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosisT Pasha, J Heathcote, S Gabriel, et al.
Transplantation Proceedings|February 1, 1987
Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patientsJ D Perkins, S Sterioff, R H Wiesner, et al.
Journal of Patient-Reported Outcomes|February 28, 2024
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapyNatalie R Dickson, Karen D Beauchamp, Toni S Perry, et al.
The New England Journal of Medicine|April 18, 1985
Trial of penicillamine in advanced primary biliary cirrhosisE R Dickson, T R Fleming, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|May 1, 1992
Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?J S Crippin, K D Lindor, R Jorgensen, et al.
Hepatology (Baltimore, Md.)|January 1, 1989
Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain alpha-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigenC D Surh, D J Danner, A Ahmed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complexD R Fregeau, P A Davis, D J Danner, et al.
Pageof 52